Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Rezolute, Inc.

3.12
+0.20006.85%
Post-market: 3.200.0800+2.56%19:58 EST
Volume:2.41M
Turnover:7.54M
Market Cap:289.31M
PE:-3.41
High:3.24
Open:2.95
Low:2.94
Close:2.92
52wk High:11.46
52wk Low:1.07
Shares:92.73M
Float Shares:78.84M
Volume Ratio:0.90
T/O Rate:3.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9151
EPS(LYR):-0.9791
ROE:-59.23%
ROA:-36.68%
PB:1.97
PE(LYR):-3.19

Loading ...

OverviewCompanyNewsFilings

Rezolute Inc. to Participate in Guggenheim Emerging Outlook Biotech Summit

Reuters
·
Feb 04

Wedbush Doubles Price Target on Rezolute to $2 From $1, Keeps Neutral Rating

MT Newswires Live
·
Jan 08

Rezolute Price Target Maintained With a $5.00/Share by BTIG

Dow Jones
·
Jan 08

BUZZ-U.S. STOCKS ON THE MOVE-Nvidia, Boeing, Lowe's

Reuters
·
Jan 08

Rezolute Shares Gain on Positive Ersodetug Indicators Despite Failure to Meet Trial Goals

Dow Jones
·
Jan 08

BUZZ-U.S. STOCKS ON THE MOVE-Hershey, Praxis Precision, Cal-Maine Foods

Reuters
·
Jan 07

BUZZ-Rezolute rises as drug shows promise for rare low blood sugar disorders

Reuters
·
Jan 07

Rezolute Inc. unveils presentation on late-stage therapies for hyperinsulinism and hypoglycemia

Reuters
·
Jan 07

Rezolute Provides Insights From Its Phase 3 Sunrize Study in Congenital Hyperinsulinism and Shares Findings From Its Expanded Access Program in Tumor Hyperinsulinism

THOMSON REUTERS
·
Jan 07

Rezolute Reports Phase 3 sunRIZE Study Results for Ersodetug in Congenital Hyperinsulinism

Reuters
·
Jan 07

Rezolute (RZLT) Valuation Revisited After Phase 3 sunRIZE Trial Misses Primary and Key Secondary Endpoints

Simply Wall St.
·
Dec 26, 2025

Rezolute Inc. Chief Medical Officer Brian Kenneth Roberts Acquires Common Shares

Reuters
·
Dec 18, 2025

Rezolute Inc. CFO Daron Evans Reports Acquisition of Common Shares

Reuters
·
Dec 16, 2025

Rezolute Inc. Chief Commercial Officer Sunil Ratilal Karnawat Acquires Common Shares

Reuters
·
Dec 16, 2025

Rezolute Is Maintained at Buy by Guggenheim

Dow Jones
·
Dec 12, 2025

Rezolute Inc : Jefferies Cuts Target Price to $4 From $20

THOMSON REUTERS
·
Dec 12, 2025

Top Midday Decliners

MT Newswires Live
·
Dec 12, 2025

Why Is XOMA Royalty Stock Sinking Thursday?

Benzinga_recent_news
·
Dec 12, 2025

Billion Dollar Genetic Disease Stock Crashes, Loses 90% Value As Lead Drug Fails In Trial

Benzinga_recent_news
·
Dec 12, 2025

Top Midday Stories: Oracle Shares Tumble After Revenue Miss; Lilly's Next-Gen Weight-Loss Drug Hits Primary Endpoints

MT Newswires Live
·
Dec 12, 2025
More